MIST
Price
$1.76
Change
+$0.04 (+2.33%)
Updated
Feb 6 closing price
Capitalization
149.9M
51 days until earnings call
Intraday BUY SELL Signals
MURA
Price
$2.08
Change
-$0.00 (-0.00%)
Updated
Oct 9 closing price
Capitalization
35.38M
51 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MIST vs MURA

Header iconMIST vs MURA Comparison
Open Charts MIST vs MURABanner chart's image
Milestone Pharmaceuticals
Price$1.76
Change+$0.04 (+2.33%)
Volume$1.62M
Capitalization149.9M
Mural Oncology
Price$2.08
Change-$0.00 (-0.00%)
Volume$46.25K
Capitalization35.38M
MIST vs MURA Comparison Chart in %
MIST
Daily Signal:
Gain/Loss:
MURA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
MIST vs. MURA commentary
Feb 09, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MIST is a Hold and MURA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 09, 2026
Stock price -- (MIST: $1.76 vs. MURA: $2.04)
Brand notoriety: MIST and MURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MIST: 27% vs. MURA: 92%
Market capitalization -- MIST: $149.9M vs. MURA: $35.38M
MIST [@Biotechnology] is valued at $149.9M. MURA’s [@Biotechnology] market capitalization is $35.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.26B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MIST’s FA Score shows that 0 FA rating(s) are green whileMURA’s FA Score has 0 green FA rating(s).

  • MIST’s FA Score: 0 green, 5 red.
  • MURA’s FA Score: 0 green, 5 red.
According to our system of comparison, both MIST and MURA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MIST’s TA Score shows that 4 TA indicator(s) are bullish while MURA’s TA Score has 1 bullish TA indicator(s).

  • MIST’s TA Score: 4 bullish, 4 bearish.
  • MURA’s TA Score: 1 bullish, 0 bearish.
According to our system of comparison, MURA is a better buy in the short-term than MIST.

Price Growth

MIST (@Biotechnology) experienced а -7.85% price change this week, while MURA (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.30%. For the same industry, the average monthly price growth was -2.98%, and the average quarterly price growth was +31.79%.

Reported Earning Dates

MIST is expected to report earnings on Mar 31, 2026.

MURA is expected to report earnings on Mar 31, 2026.

Industries' Descriptions

@Biotechnology (-2.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MIST($150M) has a higher market cap than MURA($35.4M). MURA YTD gains are higher at: 0.000 vs. MIST (-12.871). MIST has higher annual earnings (EBITDA): -54.13M vs. MURA (-131.93M). MIST has more cash in the bank: 82.6M vs. MURA (77.1M). MURA has less debt than MIST: MURA (5.17M) vs MIST (57.2M). MIST (0) and MURA (0) have equivalent revenues.
MISTMURAMIST / MURA
Capitalization150M35.4M424%
EBITDA-54.13M-131.93M41%
Gain YTD-12.8710.000-
P/E RatioN/AN/A-
Revenue00-
Total Cash82.6M77.1M107%
Total Debt57.2M5.17M1,106%
FUNDAMENTALS RATINGS
MIST: Fundamental Ratings
MIST
OUTLOOK RATING
1..100
77
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MISTMURA
RSI
ODDS (%)
Bullish Trend 3 days ago
82%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
89%
N/A
Momentum
ODDS (%)
Bearish Trend 3 days ago
78%
N/A
MACD
ODDS (%)
Bearish Trend 3 days ago
81%
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
54%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
53%
Advances
ODDS (%)
Bullish Trend 6 days ago
84%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
82%
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
81%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
57%
View a ticker or compare two or three
Interact to see
Advertisement
MIST
Daily Signal:
Gain/Loss:
MURA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MGDDF40.402.65
+7.01%
CIE GENERALE DES ETABLISSEMENTS MICHELIN SA CLERMONT-FERRAND
KNTNF19.550.73
+3.88%
K92 Mining Inc
NUVR13.650.30
+2.25%
Nuvera Communications, Inc.
ACGP40.05N/A
N/A
Associated Capital Group, Inc.
ORLCF0.04N/A
-3.01%
ORACLE COMMODITY HLDG CORP

MIST and

Correlation & Price change

A.I.dvisor tells us that MIST and AKBA have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MIST and AKBA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIST
1D Price
Change %
MIST100%
+2.33%
AKBA - MIST
33%
Poorly correlated
+0.72%
GYRE - MIST
29%
Poorly correlated
+4.93%
CADL - MIST
29%
Poorly correlated
+10.21%
PRAX - MIST
29%
Poorly correlated
+4.56%
OSRH - MIST
29%
Poorly correlated
+6.94%
More

MURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, MURA has been loosely correlated with MIST. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if MURA jumps, then MIST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MURA
1D Price
Change %
MURA100%
N/A
MIST - MURA
55%
Loosely correlated
+2.33%
CRMD - MURA
36%
Loosely correlated
+4.63%
SAVA - MURA
34%
Loosely correlated
+7.41%
DTIL - MURA
34%
Loosely correlated
+6.44%
IPSC - MURA
33%
Poorly correlated
+1.80%
More